ENTRY       hsa05208                    Pathway
NAME        Chemical carcinogenesis - reactive oxygen species - Homo sapiens (human)
DESCRIPTION It is well established that cancer is a multi-step process which involves initiation, promotion and progression. Chemical carcinogens can alter any of these processes to induce their carcinogenic effects. In the majority of instances, chemical carcinogens, directly or after xenobiotic metabolism, induce DNA damage and act in a 'genotoxic' manner. There is, however, a group of carcinogens that induce cancer via nongenotoxic mechanisms. The biochemical modes of action for nongenotoxic carcinogens are diverse, one example of which is induction of oxidative stress. Trace metals and organic xenobiotics are typical classes of environmental pollutants with prooxidant effects. Trace metals generate reactive oxygen species (ROS) depending on their ability to lose electrons and catalyze Haber Weiss and Fenton reactions. ROS are also generated due to induction of various cytochrome P450 isoenzymes during detoxification of chemical carcinogens. Increased ROS generation often has been linked to DNA damage that can lead to mutations and may, therefore, play an important role in the initiation and progression of multistage carcinogenesis. Besides causing DNA damage, ROS further induce multiple intracellular signaling pathways, notably NF-kappa B, JNK/SAPK/p38, as well as Erk/MAPK. These signaling routes can lead to transcriptional induction of target genes that could promote proliferation or confer apoptosis resistance to exposed cells.
CLASS       Human Diseases; Cancer: overview
PATHWAY_MAP hsa05208  Chemical carcinogenesis - reactive oxygen species
NETWORK     nt06210  ERK signaling (cancer)
            nt06211  Other MAPK signaling (cancer)
            nt06214  PI3K signaling (cancer)
            nt06223  TNF signaling (cancer)
            nt06225  HIF-1 signaling (cancer)
            nt06226  KEAP1-NRF2 signaling (cancer)
            nt06251  CYP-mediated ROS formation (cancer)
            nt06252  Mitochondrial ROS formation (cancer)
            nt06253  Antioxidant system (cancer)
  ELEMENT   N01389  Lead to SOD/Cat-mediated ROS neutralization
            N01390  p,p'-DDT to SOD/Cat-mediated ROS neutralization
            N01391  Lead to SOD/Cat-mediated ROS neutralization
            N01392  Arsenic to electron transfer in complex II
            N01393  Arsenic to electron transfer in complex II
            N01394  Arsenic to electron transfer in complex IV
            N01395  Cadmium to electron transfer in complex III
            N01396  4-Aminobiphenyl to CYP-mediated metabolism
            N01397  4-Aminobiphenyl to CYP-mediated metabolism
            N01398  Pentachlorophenol to CYP-mediated metabolism
            N01399  Benzene to CYP-mediated metabolism
            N01400  Benzene to CYP-mediated metabolism
            N01401  Benzo[a]pyrenre to CYP-mediated metabolism
            N01404  17beta-estradiol to CYP-mediated metabolism
            N01405  17beta-estradiol to CYP-mediated metabolism
            N01406  Ethanol to CYP-mediated metabolism
            N01407  Metals to JNK signaling pathway
            N01408  Metals to RAS-ERK signaling pathway
            N01409  Metals to PI3K signaling pathway
            N01410  Metals to NFKB signaling pathway
            N01411  Metals to NFKB signaling pathway
            N01412  Metals to HTF-1 signaling pathway
            N01413  Metals to KEAP1-NRF2 signalig pathway
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            100532726  NDUFC2-KCTD14; NDUFC2-KCTD14 readthrough [KO:K03968]
            10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
            10327  AKR1A1; aldo-keto reductase family 1 member A1 [KO:K00002] [EC:1.1.1.2]
            10476  ATP5PD; ATP synthase peripheral stalk subunit d [KO:K02138]
            107984365  [KO:K03948]
            10861  SLC26A1; solute carrier family 26 member 1 [KO:K14700]
            10975  UQCR11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            1109  AKR1C4; aldo-keto reductase family 1 member C4 [KO:K00037] [EC:1.1.1.50 1.1.1.357 1.1.1.225]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            115019  SLC26A9; solute carrier family 26 member 9 [KO:K14706]
            119391  GSTO2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]
            125965  COX6B2; cytochrome c oxidase subunit 6B2 [KO:K02267]
            126328  NDUFA11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]
            1327  COX4I1; cytochrome c oxidase subunit 4I1 [KO:K02263]
            1329  COX5B; cytochrome c oxidase subunit 5B [KO:K02265]
            1337  COX6A1; cytochrome c oxidase subunit 6A1 [KO:K02266]
            1339  COX6A2; cytochrome c oxidase subunit 6A2 [KO:K02266]
            1340  COX6B1; cytochrome c oxidase subunit 6B1 [KO:K02267]
            1345  COX6C; cytochrome c oxidase subunit 6C [KO:K02268]
            1346  COX7A1; cytochrome c oxidase subunit 7A1 [KO:K02270]
            1347  COX7A2; cytochrome c oxidase subunit 7A2 [KO:K02270]
            1349  COX7B; cytochrome c oxidase subunit 7B [KO:K02271]
            1350  COX7C; cytochrome c oxidase subunit 7C [KO:K02272]
            1351  COX8A; cytochrome c oxidase subunit 8A [KO:K02273]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]
            1537  CYC1; cytochrome c1 [KO:K00413]
            1543  CYP1A1; cytochrome P450 family 1 subfamily A member 1 [KO:K07408] [EC:1.14.14.1]
            1544  CYP1A2; cytochrome P450 family 1 subfamily A member 2 [KO:K07409] [EC:1.14.14.1]
            1545  CYP1B1; cytochrome P450 family 1 subfamily B member 1 [KO:K07410] [EC:1.14.14.1]
            1571  CYP2E1; cytochrome P450 family 2 subfamily E member 1 [KO:K07415] [EC:1.14.14.-]
            1572  CYP2F1; cytochrome P450 family 2 subfamily F member 1 [KO:K07416] [EC:1.14.14.1]
            1645  AKR1C1; aldo-keto reductase family 1 member C1 [KO:K00212] [EC:1.1.1.149 1.1.1.357 1.3.1.20]
            1646  AKR1C2; aldo-keto reductase family 1 member C2 [KO:K00089] [EC:1.1.1.213 1.1.1.357]
            170712  COX7B2; cytochrome c oxidase subunit 7B2 [KO:K02271]
            1728  NQO1; NAD(P)H quinone dehydrogenase 1 [KO:K00355] [EC:1.6.5.2]
            1836  SLC26A2; solute carrier family 26 member 2 [KO:K14701]
            1950  EGF; epidermal growth factor [KO:K04357]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            196  AHR; aryl hydrocarbon receptor [KO:K09093]
            2052  EPHX1; epoxide hydrolase 1 [KO:K01253] [EC:3.3.2.9]
            2053  EPHX2; epoxide hydrolase 2 [KO:K08726] [EC:3.3.2.10 3.1.3.76]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            221357  GSTA5; glutathione S-transferase alpha 5 [KO:K00799] [EC:2.5.1.18]
            2309  FOXO3; forkhead box O3 [KO:K09408]
            2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
            23683  PRKD3; protein kinase D3 [KO:K06070] [EC:2.7.11.13]
            25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]
            253152  EPHX4; epoxide hydrolase 4 [KO:K22369] [EC:3.3.-.-]
            25774  GSTT4; glutathione S-transferase theta 4 [KO:K00799] [EC:2.5.1.18]
            25865  PRKD2; protein kinase D2 [KO:K06070] [EC:2.7.11.13]
            27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]
            27035  NOX1; NADPH oxidase 1 [KO:K08008]
            27089  UQCRQ; ubiquinol-cytochrome c reductase complex III subunit VII [KO:K00418]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
            292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
            293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
            2938  GSTA1; glutathione S-transferase alpha 1 [KO:K00799] [EC:2.5.1.18]
            2939  GSTA2; glutathione S-transferase alpha 2 [KO:K00799] [EC:2.5.1.18]
            2940  GSTA3; glutathione S-transferase alpha 3 [KO:K00799] [EC:2.5.1.18]
            2941  GSTA4; glutathione S-transferase alpha 4 [KO:K00799] [EC:2.5.1.18]
            2944  GSTM1; glutathione S-transferase mu 1 [KO:K00799] [EC:2.5.1.18]
            2946  GSTM2; glutathione S-transferase mu 2 [KO:K00799] [EC:2.5.1.18]
            2947  GSTM3; glutathione S-transferase mu 3 [KO:K00799] [EC:2.5.1.18]
            2948  GSTM4; glutathione S-transferase mu 4 [KO:K00799] [EC:2.5.1.18]
            2949  GSTM5; glutathione S-transferase mu 5 [KO:K00799] [EC:2.5.1.18]
            2952  GSTT1; glutathione S-transferase theta 1 [KO:K00799] [EC:2.5.1.18]
            2953  GSTT2; glutathione S-transferase theta 2 (gene/pseudogene) [KO:K00799] [EC:2.5.1.18]
            29796  UQCR10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]
            3082  HGF; hepatocyte growth factor [KO:K05460]
            3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]
            3162  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            340811  AKR1C8; aldo-keto reductase family 1 member C8 [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]
            341947  COX8C; cytochrome c oxidase subunit 8C [KO:K02273]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            374291  NDUFS7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:7.1.1.2]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            4025  LPO; lactoperoxidase [KO:K12550] [EC:1.11.1.7]
            405  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
            4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
            4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
            4257  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
            4258  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
            4259  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
            440567  UQCRHL; ubiquinol-cytochrome c reductase hinge protein like [KO:K00416]
            4508  ATP6; ATP synthase F0 subunit 6 [KO:K02126]
            4509  ATP8; ATP synthase F0 subunit 8 [KO:K02125]
            4512  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:7.1.1.9]
            4513  COX2; cytochrome c oxidase subunit II [KO:K02261]
            4514  COX3; cytochrome c oxidase subunit III [KO:K02262]
            4519  CYTB; cytochrome b [KO:K00412]
            4535  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]
            4536  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]
            4537  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]
            4538  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]
            4539  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]
            4540  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]
            4541  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]
            4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]
            4694  NDUFA1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]
            4695  NDUFA2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]
            4696  NDUFA3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]
            4697  NDUFA4; NDUFA4 mitochondrial complex associated [KO:K03948]
            4698  NDUFA5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]
            4700  NDUFA6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]
            4701  NDUFA7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]
            4702  NDUFA8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]
            4704  NDUFA9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]
            4705  NDUFA10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]
            4706  NDUFAB1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]
            4707  NDUFB1; NADH:ubiquinone oxidoreductase subunit B1 [KO:K03957]
            4708  NDUFB2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]
            4709  NDUFB3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]
            4710  NDUFB4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]
            4711  NDUFB5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]
            4712  NDUFB6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]
            4713  NDUFB7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]
            4714  NDUFB8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]
            4715  NDUFB9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]
            4716  NDUFB10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]
            4717  NDUFC1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]
            4718  NDUFC2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]
            4719  NDUFS1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:7.1.1.2]
            4720  NDUFS2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:7.1.1.2]
            4722  NDUFS3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:7.1.1.2]
            4723  NDUFV1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:7.1.1.2]
            4724  NDUFS4; NADH:ubiquinone oxidoreductase subunit S4 [KO:K03937]
            4725  NDUFS5; NADH:ubiquinone oxidoreductase subunit S5 [KO:K03938]
            4726  NDUFS6; NADH:ubiquinone oxidoreductase subunit S6 [KO:K03939]
            4728  NDUFS8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:7.1.1.2]
            4729  NDUFV2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:7.1.1.2]
            4731  NDUFV3; NADH:ubiquinone oxidoreductase subunit V3 [KO:K03944]
            4780  NFE2L2; NFE2 like bZIP transcription factor 2 [KO:K05638]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            498  ATP5F1A; ATP synthase F1 subunit alpha [KO:K02132]
            50507  NOX4; NADPH oxidase 4 [KO:K21423] [EC:1.6.3.-]
            506  ATP5F1B; ATP synthase F1 subunit beta [KO:K02133] [EC:7.1.2.2]
            509  ATP5F1C; ATP synthase F1 subunit gamma [KO:K02136]
            51079  NDUFA13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]
            513  ATP5F1D; ATP synthase F1 subunit delta [KO:K02134]
            514  ATP5F1E; ATP synthase F1 subunit epsilon [KO:K02135]
            515  ATP5PB; ATP synthase peripheral stalk-membrane subunit b [KO:K02127]
            516  ATP5MC1; ATP synthase membrane subunit c locus 1 [KO:K02128]
            517  ATP5MC2; ATP synthase membrane subunit c locus 2 [KO:K02128]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            518  ATP5MC3; ATP synthase membrane subunit c locus 3 [KO:K02128]
            52  ACP1; acid phosphatase 1 [KO:K14394] [EC:3.1.3.2 3.1.3.48]
            522  ATP5PF; ATP synthase peripheral stalk subunit F6 [KO:K02131]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
            5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
            539  ATP5PO; ATP synthase peripheral stalk subunit OSCP [KO:K02137]
            54539  NDUFB11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]
            5580  PRKCD; protein kinase C delta [KO:K06068] [EC:2.7.11.13]
            5587  PRKD1; protein kinase D1 [KO:K06070] [EC:2.7.11.13]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            55967  NDUFA12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            56901  NDUFA4L2; NDUFA4 mitochondrial complex associated like 2 [KO:K03948]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
            57412  AS3MT; arsenite methyltransferase [KO:K07755] [EC:2.1.1.137]
            5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
            5770  PTPN1; protein tyrosine phosphatase non-receptor type 1 [KO:K05696] [EC:3.1.3.48]
            5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            5795  PTPRJ; protein tyrosine phosphatase receptor type J [KO:K05698] [EC:3.1.3.48]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6389  SDHA; succinate dehydrogenase complex flavoprotein subunit A [KO:K00234] [EC:1.3.5.1]
            6390  SDHB; succinate dehydrogenase complex iron sulfur subunit B [KO:K00235] [EC:1.3.5.1]
            6391  SDHC; succinate dehydrogenase complex subunit C [KO:K00236]
            6392  SDHD; succinate dehydrogenase complex subunit D [KO:K00237]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            65010  SLC26A6; solute carrier family 26 member 6 [KO:K14704]
            653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]
            653689  GSTT2B; glutathione S-transferase theta 2B [KO:K00799] [EC:2.5.1.18]
            6647  SOD1; superoxide dismutase 1 [KO:K04565] [EC:1.15.1.1]
            6648  SOD2; superoxide dismutase 2 [KO:K04564] [EC:1.15.1.1]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
            7381  UQCRB; ubiquinol-cytochrome c reductase binding protein [KO:K00417]
            7384  UQCRC1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]
            7385  UQCRC2; ubiquinol-cytochrome c reductase core protein 2 [KO:K00415]
            7386  UQCRFS1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]
            7388  UQCRH; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]
            7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]
            7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]
            7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            79852  EPHX3; epoxide hydrolase 3 [KO:K22368] [EC:3.3.2.10]
            83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
            847  CAT; catalase [KO:K03781] [EC:1.11.1.6]
            84701  COX4I2; cytochrome c oxidase subunit 4I2 [KO:K02263]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            8644  AKR1C3; aldo-keto reductase family 1 member C3 [KO:K04119] [EC:1.1.1.51 1.1.1.188 1.1.1.213 1.1.1.357]
            873  CBR1; carbonyl reductase 1 [KO:K00079] [EC:1.1.1.184 1.1.1.189 1.1.1.197]
            9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
            9167  COX7A2L; cytochrome c oxidase subunit 7A2 like [KO:K02270]
            9377  COX5A; cytochrome c oxidase subunit 5A [KO:K02264]
            9446  GSTO1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]
            9817  KEAP1; kelch like ECH associated protein 1 [KO:K10456]
COMPOUND    C00001  H2O
            C00003  NAD+
            C00005  NADPH
            C00006  NADP+
            C00007  Oxygen
            C00019  S-Adenosyl-L-methionine
            C00021  S-Adenosyl-L-homocysteine
            C00023  Iron
            C00027  Hydrogen peroxide
            C00051  Glutathione
            C00070  Copper
            C00084  Acetaldehyde
            C00127  Glutathione disulfide
            C00146  Phenol
            C00291  Nickel
            C00469  Ethanol
            C00472  p-Benzoquinone
            C00530  Hydroquinone
            C00704  Superoxide
            C00951  Estradiol-17beta
            C01407  Benzene
            C01413  Cadmium
            C01782  Benzene oxide
            C02389  p-Benzosemiquinone
            C02575  Pentachlorophenol
            C02814  Benzene-1,2,4-triol
            C03434  Tetrachlorohydroquinone
            C03622  N-Hydroxy-4-aminobiphenyl
            C04623  DDT
            C05301  2-Hydroxyestradiol
            C05309  Semiquinone
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C06268  Chromium
            C06269  Arsenic
            C06696  Lead
            C07294  Methylarsonate
            C07295  Methanearsonous acid
            C07308  Cacodylate
            C07535  Benzo[a]pyrene
            C07557  2,3,7,8-Tetrachlorodibenzodioxin
            C10998  4-Aminobiphenyl
            C14209  4-Hydroxy-17beta-estradiol
            C14850  Benzo[a]pyrene-7,8-oxide
            C14852  Benzo[a]pyrene-7,8-dihydrodiol
            C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
            C16453  4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone
            C16844  Hydroxyl radical
            C18205  2,2',4,4'-Tetrabromodiphenyl ether
            C18933  Chloranil
            C19171  Cobalt
            C20300  Dimethylarsinous acid
            C20316  4-Nitrosobiphenyl
            C20319  Hydronitroxide radical
            C22355  Benzo[a]pyrene-7,8-diol
            C22356  Benzo[a]pyrene-7,8-dione
            C22357  17beta-Estradiol-2,3-quinone
            C22381  Reactive oxygen species
REFERENCE   PMID:24281075
  AUTHORS   Henkler F, Brinkmann J, Luch A
  TITLE     The role of oxidative stress in carcinogenesis induced by metals and xenobiotics.
  JOURNAL   Cancers (Basel) 2:376-96 (2010)
            DOI:10.3390/cancers2020376
REFERENCE   PMID:22705365
  AUTHORS   Lee JC, Son YO, Pratheeshkumar P, Shi X
  TITLE     Oxidative stress and metal carcinogenesis.
  JOURNAL   Free Radic Biol Med 53:742-57 (2012)
            DOI:10.1016/j.freeradbiomed.2012.06.002
REFERENCE   PMID:32033297
  AUTHORS   Hu Y, Li J, Lou B, Wu R, Wang G, Lu C, Wang H, Pi J, Xu Y
  TITLE     The Role of Reactive Oxygen Species in Arsenic Toxicity.
  JOURNAL   Biomolecules 10:E240 (2020)
            DOI:10.3390/biom10020240
REFERENCE   PMID:33864199
  AUTHORS   Ozturk M, Metin M, Altay V, Bhat RA, Ejaz M, Gul A, Unal BT, Hasanuzzaman M, Nibir L, Nahar K, Bukhari A, Dervash MA, Kawano T
  TITLE     Arsenic and Human Health: Genotoxicity, Epigenomic Effects, and Cancer Signaling.
  JOURNAL   Biol Trace Elem Res 10.1007/s12011-021-02719-w (2021)
            DOI:10.1007/s12011-021-02719-w
REFERENCE   PMID:23510327
  AUTHORS   Hubaux R, Becker-Santos DD, Enfield KS, Rowbotham D, Lam S, Lam WL, Martinez VD
  TITLE     Molecular features in arsenic-induced lung tumors.
  JOURNAL   Mol Cancer 12:20 (2013)
            DOI:10.1186/1476-4598-12-20
REFERENCE   PMID:21648415
  AUTHORS   Naranmandura H, Xu S, Sawata T, Hao WH, Liu H, Bu N, Ogra Y, Lou YJ, Suzuki N
  TITLE     Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.
  JOURNAL   Chem Res Toxicol 24:1094-103 (2011)
            DOI:10.1021/tx200156k
REFERENCE   PMID:23583964
  AUTHORS   Faita F, Cori L, Bianchi F, Andreassi MG
  TITLE     Arsenic-induced genotoxicity and genetic susceptibility to arsenic-related pathologies.
  JOURNAL   Int J Environ Res Public Health 10:1527-46 (2013)
            DOI:10.3390/ijerph10041527
REFERENCE   PMID:28179585
  AUTHORS   Sage AP, Minatel BC, Ng KW, Stewart GL, Dummer TJB, Lam WL, Martinez VD
  TITLE     Oncogenomic disruptions in arsenic-induced carcinogenesis.
  JOURNAL   Oncotarget 8:25736-25755 (2017)
            DOI:10.18632/oncotarget.15106
REFERENCE   PMID:21414382
  AUTHORS   Jomova K, Valko M
  TITLE     Advances in metal-induced oxidative stress and human disease.
  JOURNAL   Toxicology 283:65-87 (2011)
            DOI:10.1016/j.tox.2011.03.001
REFERENCE   PMID:16430879
  AUTHORS   Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M
  TITLE     Free radicals, metals and antioxidants in oxidative stress-induced cancer.
  JOURNAL   Chem Biol Interact 160:1-40 (2006)
            DOI:10.1016/j.cbi.2005.12.009
REFERENCE   PMID:32731582
  AUTHORS   Tumolo M, Ancona V, De Paola D, Losacco D, Campanale C, Massarelli C, Uricchio VF
  TITLE     Chromium Pollution in European Water, Sources, Health Risk, and Remediation Strategies: An Overview.
  JOURNAL   Int J Environ Res Public Health 17:E5438 (2020)
            DOI:10.3390/ijerph17155438
REFERENCE   PMID:28860815
  AUTHORS   Wang Y, Su H, Gu Y, Song X, Zhao J
  TITLE     Carcinogenicity of chromium and chemoprevention: a brief update.
  JOURNAL   Onco Targets Ther 10:4065-4079 (2017)
            DOI:10.2147/OTT.S139262
REFERENCE   PMID:24820114
  AUTHORS   Jin X, Chen M, Song L, Li H, Li Z
  TITLE     The evaluation of p,p'-DDT exposure on cell adhesion of hepatocellular carcinoma.
  JOURNAL   Toxicology 322:99-108 (2014)
            DOI:10.1016/j.tox.2014.05.002
REFERENCE   PMID:20370557
  AUTHORS   Liou GY, Storz P
  TITLE     Reactive oxygen species in cancer.
  JOURNAL   Free Radic Res 44:479-96 (2010)
            DOI:10.3109/10715761003667554
REFERENCE   PMID:11275476
  AUTHORS   Murata M, Tamura A, Tada M, Kawanishi S
  TITLE     Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl.
  JOURNAL   Free Radic Biol Med 30:765-73 (2001)
            DOI:10.1016/S0891-5849(01)00463-4
REFERENCE   PMID:31283132
  AUTHORS   
  TITLE     
  JOURNAL   Pentachlorophenol and Some Related Compounds (2019)
REFERENCE   PMID:19408893
  AUTHORS   Zhu BZ, Shan GQ
  TITLE     Potential mechanism for pentachlorophenol-induced carcinogenicity: a novel mechanism for metal-independent production of hydroxyl radicals.
  JOURNAL   Chem Res Toxicol 22:969-77 (2009)
            DOI:10.1021/tx900030v
REFERENCE   PMID:22166497
  AUTHORS   McHale CM, Zhang L, Smith MT
  TITLE     Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment.
  JOURNAL   Carcinogenesis 33:240-52 (2012)
            DOI:10.1093/carcin/bgr297
REFERENCE   PMID:32977499
  AUTHORS   Scharf P, Broering MF, Oliveira da Rocha GH, Farsky SHP
  TITLE     Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis.
  JOURNAL   Int J Mol Sci 21:E6996 (2020)
            DOI:10.3390/ijms21196996
REFERENCE   PMID:23066403
  AUTHORS   Snyder R
  TITLE     Leukemia and benzene.
  JOURNAL   Int J Environ Res Public Health 9:2875-93 (2012)
            DOI:10.3390/ijerph9082875
REFERENCE   PMID:9118888
  AUTHORS   Snyder R, Hedli CC
  TITLE     An overview of benzene metabolism.
  JOURNAL   Environ Health Perspect 104 Suppl 6:1165-71 (1996)
            DOI:10.1289/ehp.961041165
REFERENCE   PMID:11978484
  AUTHORS   Kawanishi S, Hiraku Y, Murata M, Oikawa S
  TITLE     The role of metals in site-specific DNA damage with reference to carcinogenesis.
  JOURNAL   Free Radic Biol Med 32:822-32 (2002)
            DOI:10.1016/S0891-5849(02)00779-7
REFERENCE   PMID:27919191
  AUTHORS   Das DN, Panda PK, Naik PP, Mukhopadhyay S, Sinha N, Bhutia SK
  TITLE     Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.
  JOURNAL   Toxicol Mech Methods 27:1-17 (2017)
            DOI:10.1080/15376516.2016.1268228
REFERENCE   PMID:21910479
  AUTHORS   Shultz CA, Quinn AM, Park JH, Harvey RG, Bolton JL, Maser E, Penning TM.
  TITLE     Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
  JOURNAL   Chem Res Toxicol 24:2153-66 (2011)
            DOI:10.1021/tx200294c
REFERENCE   PMID:25279998
  AUTHORS   Penning TM
  TITLE     Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
  JOURNAL   Chem Res Toxicol 27:1901-17 (2014)
            DOI:10.1021/tx500298n
REFERENCE   PMID:10706104
  AUTHORS   Burczynski ME, Penning TM
  TITLE     Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor.
  JOURNAL   Cancer Res 60:908-15 (2000)
REFERENCE   PMID:15963346
  AUTHORS   Xue W, Warshawsky D
  TITLE     Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review.
  JOURNAL   Toxicol Appl Pharmacol 206:73-93 (2005)
            DOI:10.1016/j.taap.2004.11.006
REFERENCE   PMID:15142886
  AUTHORS   Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, Surh YJ
  TITLE     Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
  JOURNAL   Carcinogenesis 25:2005-13 (2004)
            DOI:10.1093/carcin/bgh183
REFERENCE   PMID:16684662
  AUTHORS   Rifkind AB
  TITLE     CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates.
  JOURNAL   Drug Metab Rev 38:291-335 (2006)
            DOI:10.1080/03602530600570107
REFERENCE   PMID:9380738
  AUTHORS   Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG
  TITLE     Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
  JOURNAL   Proc Natl Acad Sci U S A 94:10937-42 (1997)
            DOI:10.1073/pnas.94.20.10937
REFERENCE   PMID:9472688
  AUTHORS   Zhu BT, Conney AH
  TITLE     Functional role of estrogen metabolism in target cells: review and perspectives.
  JOURNAL   Carcinogenesis 19:1-27 (1998)
            DOI:10.1093/carcin/19.1.1
REFERENCE   PMID:19387921
  AUTHORS   McKillop IH, Schrum LW
  TITLE     Role of alcohol in liver carcinogenesis.
  JOURNAL   Semin Liver Dis 29:222-32 (2009)
            DOI:10.1055/s-0029-1214377
REFERENCE   PMID:15603755
  AUTHORS   Gonzalez FJ
  TITLE     Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.
  JOURNAL   Mutat Res 569:101-10 (2005)
            DOI:10.1016/j.mrfmmm.2004.04.021
REFERENCE   PMID:31864052
  AUTHORS   Montalbano AM, Albano GD, Anzalone G, Moscato M, Gagliardo R, Di Sano C, Bonanno A, Ruggieri S, Cibella F, Profita M
  TITLE     Cytotoxic and genotoxic effects of the flame retardants (PBDE-47, PBDE-99 and PBDE-209) in human bronchial epithelial cells.
  JOURNAL   Chemosphere 245:125600 (2020)
            DOI:10.1016/j.chemosphere.2019.125600
REFERENCE   PMID:33907575
  AUTHORS   Sun HN, Ren CX, Gong YX, Xie DP, Kwon T
  TITLE     Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development.
  JOURNAL   Oncol Lett 21:465 (2021)
            DOI:10.3892/ol.2021.12726
REFERENCE   PMID:25372613
  AUTHORS   Pluchino LA, Wang HC
  TITLE     Chronic exposure to combined carcinogens enhances breast cell carcinogenesis with mesenchymal and stem-like cell properties.
  JOURNAL   PLoS One 9:e108698 (2014)
            DOI:10.1371/journal.pone.0108698
REFERENCE   PMID:25535943
  AUTHORS   Pluchino LA, Liu AK, Wang HC
  TITLE     Reactive oxygen species-mediated breast cell carcinogenesis enhanced by multiple carcinogens and intervened by dietary ergosterol and mimosine.
  JOURNAL   Free Radic Biol Med 80:12-26 (2015)
            DOI:10.1016/j.freeradbiomed.2014.12.015
REFERENCE   PMID:30327380
  AUTHORS   Moldogazieva NT, Lutsenko SV, Terentiev AA
  TITLE     Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.
  JOURNAL   Cancer Res 78:6040-6047 (2018)
            DOI:10.1158/0008-5472.CAN-18-0980
REFERENCE   PMID:32358622
  AUTHORS   Kirtonia A, Sethi G, Garg M
  TITLE     The multifaceted role of reactive oxygen species in tumorigenesis.
  JOURNAL   Cell Mol Life Sci 77:4459-4483 (2020)
            DOI:10.1007/s00018-020-03536-5
REFERENCE   PMID:29449774
  AUTHORS   Kumari S, Badana AK, G MM, G S, Malla R
  TITLE     Reactive Oxygen Species: A Key Constituent in Cancer Survival.
  JOURNAL   Biomark Insights 13:1177271918755391 (2018)
            DOI:10.1177/1177271918755391
REFERENCE   PMID:28881698
  AUTHORS   Gao X, Schottker B
  TITLE     Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.
  JOURNAL   Oncotarget 8:51888-51906 (2017)
            DOI:10.18632/oncotarget.17128
REFERENCE   PMID:15769673
  AUTHORS   Storz P
  TITLE     Reactive oxygen species in tumor progression.
  JOURNAL   Front Biosci 10:1881-96 (2005)
            DOI:10.2741/1667
REFERENCE   PMID:28835450
  AUTHORS   Assi M
  TITLE     The differential role of reactive oxygen species in early and late stages of cancer.
  JOURNAL   Am J Physiol Regul Integr Comp Physiol 313:R646-R653 (2017)
            DOI:10.1152/ajpregu.00247.2017
REFERENCE   PMID:15024053
  AUTHORS   Storz P, Doppler H, Toker A
  TITLE     Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.
  JOURNAL   Mol Cell Biol 24:2614-26 (2004)
            DOI:10.1128/MCB.24.7.2614-2626.2004
REFERENCE   PMID:24998536
  AUTHORS   Nourazarian AR, Kangari P, Salmaninejad A
  TITLE     Roles of oxidative stress in the development and progression of breast cancer.
  JOURNAL   Asian Pac J Cancer Prev 15:4745-51 (2014)
            DOI:10.7314/apjcp.2014.15.12.4745
REFERENCE   PMID:32336668
  AUTHORS   Zheng F, Goncalves FM, Abiko Y, Li H, Kumagai Y, Aschner M
  TITLE     Redox toxicology of environmental chemicals causing oxidative stress.
  JOURNAL   Redox Biol 34:101475 (2020)
            DOI:10.1016/j.redox.2020.101475
REL_PATHWAY hsa00190  Oxidative phosphorylation
            hsa00980  Metabolism of xenobiotics by cytochrome P450
            hsa04010  MAPK signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04370  VEGF signaling pathway
            hsa05207  Chemical carcinogenesis - receptor activation
            hsa05211  Renal cell carcinoma
            hsa05215  Prostate cancer
            hsa05219  Bladder cancer
            hsa05221  Acute myeloid leukemia
            hsa05222  Small cell lung cancer
            hsa05223  Non-small cell lung cancer
            hsa05224  Breast cancer
            hsa05225  Hepatocellular carcinoma
KO_PATHWAY  ko05208
///
